Tipifarnib in Treating Patients With Anemia or Neutropenia and Large Granular Lymphocyte Leukemia
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This phase II trial is studying how well tipifarnib works in treating patients with anemia or
neutropenia and large granular lymphocyte leukemia. Tipifarnib may stop the growth of
leukemia by blocking blood flow to the cancer cells and by blocking some of the enzymes
needed for cancer cell growth.